GURUFOCUS.COM » STOCK LIST » USA » OTCPK » BioQuest Corp (OTCPK:BQST) » Definitions » EV-to-EBIT
Switch to:

BioQuest (OTCPK:BQST) EV-to-EBIT

: -49.78 (As of Today)
View and export this data going back to 2013. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BioQuest's Enterprise Value is $22.45 Mil. BioQuest's EBIT for the trailing twelve months (TTM) ended in Jul. 2022 was $-0.45 Mil. Therefore, BioQuest's EV-to-EBIT for today is -49.78.

The historical rank and industry rank for BioQuest's EV-to-EBIT or its related term are showing as below:

BQST' s EV-to-EBIT Range Over the Past 10 Years
Min: -262.37   Med: -0.42   Max: 0.1
Current: -49.78

During the past 6 years, the highest EV-to-EBIT of BioQuest was 0.10. The lowest was -262.37. And the median was -0.42.

BQST's EV-to-EBIT is ranked worse than
100% of 666 companies
in the Drug Manufacturers industry
Industry Median: 15.97 vs BQST: -49.78

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. BioQuest's Enterprise Value for the quarter that ended in Jul. 2022 was $10.96 Mil. BioQuest's EBIT for the trailing twelve months (TTM) ended in Jul. 2022 was $-0.45 Mil. BioQuest's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2022 was -4.11%.

BioQuest EV-to-EBIT Historical Data

The historical data trend for BioQuest's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioQuest Annual Data
Trend Apr12 Apr13 Apr14 Apr20 Apr21 Apr22
EV-to-EBIT
Premium Member Only - -82.94 -310.57 -3.85 -8.13

BioQuest Quarterly Data
Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.84 -4.51 -4.99 -8.13 -24.31
Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioQuest's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   
BioQuest EV-to-EBIT Distribution

For the Drug Manufacturers industry and Healthcare sector, BioQuest's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BioQuest's EV-to-EBIT falls in comparison to its industry or sector. The grey bar indicates the EV-to-EBIT's extreme value range as defined by GuruFocus.


BioQuest EV-to-EBIT Calculation

BioQuest's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=22.450/-0.451
=-49.78

BioQuest's current Enterprise Value is $22.45 Mil.
BioQuest's EBIT for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioQuest  (OTCPK:BQST) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

BioQuest's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jul. 2022 ) =EBIT / Enterprise Value (Q: Jul. 2022 )
=-0.451/10.964088
=-4.11 %

BioQuest's Enterprise Value for the quarter that ended in Jul. 2022 was $10.96 Mil.
BioQuest's EBIT for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioQuest EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of BioQuest's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BioQuest (OTCPK:BQST) Business Description

BioQuest logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioQuest Corp (OTCPK:BQST) » Definitions » EV-to-EBIT
Comparable Companies
XCNQ:IP BOM:532387 BOM:532092 OTCPK:OHGI BOM:532275 ROCO:8458 LSE:AEO OTCPK:AFTM WAR:PGM BOM:532380 XKRX:200350 XKRX:220110 BOM:590070 BOM:541703 BOM:500329 XTER:WBAH BOM:540084 OTCPK:AFOM FRA:HBD1 OTCPK:EMPM
Traded in Other Exchanges
N/A
Address
4570 Campus Drive, Suite 23, Newport Beach, CA, USA, 92660
Website
https://www.bioquestcorp.com
BioQuest Corp markets, packages, and distributes Hemp-CBD based. The company products include CBD tincture oils, topical face and body lotions, cooking spice products infused with CBD, and Pet products. It serves health and wellness, nutraceutical as well as the hemp farming industries.